Email Facebook Twitter


MEDIA-Reckitt Benckiser pharma spin-off launch expected this week - FT

-- Source link: ( Note: Reuters has not verified this story and does not
[Mon 00:31]

UPDATE 4-Virgin America soars in market debut

* Shares rise 31 pct* Company valued at about $1.3 bln* Richard Branson retains 24.8 pct stake
[14 Nov '14]

Mota-Engil to list African unit in Amsterdam, no IPO for now

LISBON, Nov 14 (Reuters) - Portugal's largest builder
[14 Nov '14]

BUZZ-FibroGen: Shares up in strong debut, IPO size increased

** Shares of biopharmaceutical company focused on treatment
[14 Nov '14]

Virgin America shares jump 24.3 pct in debut

Nov 14 (Reuters) - Shares of Virgin America Inc, a
[14 Nov '14]

CORRECTED-UPDATE 1-Virgin America IPO priced at $23/shr-underwriter

(Correcta paragraph two to say "priced slightly below the top
[14 Nov '14]

Virgin Money attracts top investors ahead of IPO -Sky News

Nov 14 (Reuters) - Toscafund, an investment manager that has
[14 Nov '14]

BUZZ-Regulus Therapeutics: Strategic Partner reduces stake

** Regulus shares down about 7 pct premarket as
[13 Nov '14]

UPDATE 1-Turkish pension firm Avivasa debut lifts Sabanci listed firms to 12

(Adds Sabanci details, updates share price)ISTANBUL, Nov 13 (Reuters) - Avivasa, the Turkish
[13 Nov '14]

UPDATE 2-Lukewarm Virgin Money debut nets $220 mln for Branson, Ross

* Priced at 283 pence/share, values business at 1.25 bln stg* Backers Branson, Ross to make around 70 mln stg each from
[13 Nov '14]

Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.